Evaluating Your Current Options in the Treatment of NSCLC with METex14 Skipping Mutations
Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on May 27, 2023 09:55 ()
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 354914454 series 3128163
Valid until: 02-11-2023
Claim your CME credit at https://reachmd.com/programs/cme/evaluating-your-current-options-in-the-treatment-of-nsclc-with-metex14-skipping-mutations/14089/
Take a deep dive into current and ongoing clinical trials related to MET inhibitors and discover the key distinctions between these agents, such as dosing differences. Our experts also have recommendations on appropriate therapy selection for your patients with advanced NSCLC harboring MET exon 14 skipping mutations.